Screening starts at 30, not 45. The national guideline does not diagnose on HbA1c. And there is no glucagon to prescribe.
Pakistan has the highest national prevalence of type 2 diabetes in the world — 26.7%. Over a quarter of Pakistanis with diabetes are under 40. That single fact is why the screening age here is not the one you were taught.
Every recommendation here carries a divergence badge.Same as international guidelinePakistan-adaptedLocal data onlyNational guideline outdated
Two national documents, and they do different jobs. PROMPT is the practical national guideline, written explicitly for resource-constrained settings with affordability and availability in mind. The 2023 adolopment is a formal GRADE adaptation of ADA 2021 — of 243 ADA recommendations, 219 were adopted unchanged, 5 took minor changes, 1 was adapted and 18 were excluded. Where they overlap, this page follows PROMPT for practical choices and the adolopment for what ADA does and does not transfer.
Decision-support only, and note the scope. This pathway covers screening, diagnosis, targets and initial agent choice. It does not cover complications screening, insulin titration, or inpatient and paediatric diabetes — the last two because the Pakistani adolopment excluded them from its own scope, so there is no national position to report.
✓ Clinically reviewed by Dr Soban Bin Salman Meer, MBBS · 05 Aug 2026.
Step 1 · Who to screen, and the RAPID score
GRADE-adolopment 2023 · PROMPT
Screening starts at 30 here, not 45 Pakistan-adapted
The recommended age to begin screening all individuals for T2DM and pre-diabetes was lowered from 45 to 30 years, due to the higher prevalence of T2DM in younger Pakistanis.
Pakistan has a T2DM prevalence of 26.7% — the highest national prevalence in the world.
Over 25% of Pakistanis with diabetes are aged under 40, and 50% are between 40 and 59.
South Asian populations carry particularly high risk, attributed to poor maternal nutrition, high rates of childhood obesity and dietary factors.
Screening later means more patients present through the onset of systemic complications — tertiary prevention rather than primary.
Younger patients have greater capacity for lifestyle modification and tend to be more proactive about their health.
Most healthcare expenditure in Pakistan is out of pocket, so earlier detection has the potential to be cost-saving to the patient — a crucial benefit in a low- and middle-income setting.
RAPID — the Pakistan-specific risk score Local data only
PROMPT endorses the Risk Assessment of Pakistani Individuals for Diabetes score for population-based screening. It exists because risk scores built on European cohorts under-call risk in South Asians, particularly at lower BMI.
Note the waist cut-offs: 80 cm in women and 90 cm in men, not the European thresholds. South Asians develop metabolic risk at lower waist circumference and lower BMI.
Step 2 · How to diagnose
PROMPT
The national guideline does not use HbA1c to diagnose Pakistan-adapted
Test
Diagnostic threshold
Fasting plasma glucose
≥ 126 mg/dL (≥ 7.0 mmol/L)
Random plasma glucose
≥ 200 mg/dL (11.1 mmol/L)
2-hour post-glucose load
≥ 200 mg/dL (11.1 mmol/L)
On HbA1c.International bodies are now recommending HbA1c as diagnostic criteria but national and regional studies are required before it can be included in national guidelines.
This is a deliberate national position, not an oversight. HbA1c performance varies with haemoglobinopathies, iron deficiency and anaemia — all common in Pakistan — and the guideline held off pending national validation data. Use HbA1c for monitoring; diagnose on glucose.
Why it is flagged: ADA and WHO both accept HbA1c as a diagnostic criterion. The Pakistani national guideline explicitly does not, pending local validation.
Step 3 · Targets
PROMPT
PROMPT glycaemic targets Local data only
Patient group
Fasting
Random
Bedtime
HbA1c
Without complications
80–120 mg/dL
80–160 mg/dL
100–140 mg/dL
6.5–7.0%
With cardiac failure, chronic kidney disease, chronic liver disease or autonomic neuropathy
80–160 mg/dL
120–180 mg/dL
120–180 mg/dL
7.0–7.5%
The row that gets forgotten. The relaxed row is the one that gets forgotten. A patient with heart failure or advanced kidney disease chased to an HbA1c of 6.5% is being exposed to hypoglycaemia for no benefit — and in Pakistan, without a glucagon rescue option.
Step 4 · What to start
PROMPT
Metformin, for everyone, regardless of BMI Same as international guideline
Metformin should be prescribed to all patients along with lifestyle modifications, irrespective of their baseline BMI, if there are no contraindications.
Why the BMI clause matters here. The "irrespective of BMI" clause matters in South Asians, who develop T2DM at lower BMI than European populations — a lean patient is not a reason to withhold metformin.
One thing to tell the patient. Anorexia, nausea, diarrhoea and a metallic taste are minimised by taking it with meals. That single piece of advice prevents a lot of early discontinuation.
If metformin is contraindicated or not tolerated Same as international guideline
Sulphonylureas
Cheap and widely available, which in an out-of-pocket system is a real clinical advantage. The trade-off is hypoglycaemia risk — which matters more here, because glucagon rescue is not available.
DPP-4 inhibitors
Weight-neutral and low hypoglycaemia risk, at higher cost.
Insulin
Named by PROMPT as an option where metformin cannot be used, not only as a late-stage agent.
PROMPT also lists alpha-glucosidase inhibitors, GLP-1 agonists, thiazolidinediones and repaglinide among available options.
Cost is a clinical variable here, not an administrative one Pakistan-adapted
Most healthcare expenditure in Pakistan is out of pocket. The adolopment authors state plainly that burdensome medical expenses can negatively impact patients' lives or interfere with their adherence to therapy. A regimen the patient stops paying for in month three is worse than a cheaper one they continue.
Why it is flagged: ADA recommendations assume an insurance-based system. The Pakistani adaptation explicitly excluded two recommendations that depended on private insurance.
Step 5 · What ADA recommends that you cannot do here
GRADE-adolopment 2023
What ADA recommends that you cannot do here Pakistan-adapted
Of 243 ADA 2021 recommendations, 18 were excluded from the Pakistani guideline. The categories are documented:
Category
Count
Reason
Inpatient care
10
Outside the scope the guideline centres set for themselves.
Paediatric management
4
Outside scope for the same reason.
Dependent on private insurance
2
Not applicable to the Pakistani healthcare system, where most expenditure is out of pocket.
Medication unavailable in Pakistan
2
The drug simply cannot be obtained.
The one exclusion named explicitly, and it matters clinically
The recommendation to prescribe glucagon for patients at risk of hypoglycaemia was excluded because glucagon is not available in Pakistan. There is no glucagon rescue kit to give the family of a patient on insulin or a sulphonylurea. That changes how you should weigh hypoglycaemia risk when choosing an agent, how hard you chase a tight target, and what you teach the family about treating a hypo.
Continuous glucose monitoring. Continuous glucose monitoring is described as unaffordable for most Pakistani patients. Recommendations that assume it are not actionable for the majority.
Step 6 · How much weight to put on this
The authors' own account
How much weight to put on all this Local data only
The adolopment authors are unusually candid about their own limitations, and it is worth knowing. They state there are not enough original articles published based on the Pakistani population, and that the process relied on regional literature, judicious use of grey literature, and expert consensus informed by a suboptimal level of evidence.
Challenges the authors name:
Inadequate original Pakistani research data
Limited local expertise in guideline development methodology
Insufficient workforce and funding
No patient, general practitioner or allied health perspectives included
Institutional hierarchy inhibiting frank discussion among the panel
The fair reading. That does not make the guideline wrong — it makes it the best available synthesis for a country where the research base is thin. Read the screening age and the availability exclusions as solid; read fine-grained treatment sequencing as expert opinion adapted from ADA.
Two areas PROMPT points elsewhere for
Ramadan
PROMPT defers to the IDF Diabetes and Ramadan Alliance guidelines, with national adaptation intended. Pre-Ramadan risk stratification and dose adjustment are not covered by the national diabetes guideline itself.
Gestational diabetes
PROMPT notes GDM guidelines were being developed separately by a national advocacy board, following projects screening around 25,000 pregnant women. Use dedicated GDM guidance rather than extrapolating from this pathway.
Common questions
At what age should diabetes screening start in Pakistan?
Thirty. The Pakistani adolopment of the ADA guideline lowered the screening age from 45 to 30 because of the higher prevalence of T2DM in younger Pakistanis — over a quarter of Pakistanis with diabetes are under 40, and national prevalence is 26.7%, the highest in the world.
Can I diagnose diabetes on HbA1c in Pakistan?
The national guideline does not endorse it. PROMPT states that international bodies recommend HbA1c as a diagnostic criterion but that national and regional studies are required before it can be included in national guidelines. Diagnose on fasting plasma glucose of 126 mg/dL or more, random or 2-hour post-load glucose of 200 mg/dL or more. Use HbA1c for monitoring.
What is the RAPID score?
Risk Assessment of Pakistani Individuals for Diabetes — the Pakistan-specific screening score PROMPT endorses. Age 40 to 50 scores 1, over 50 scores 3, waist above 80 cm in women or 90 cm in men scores 2, and family history of diabetes scores 1. A total of 4 or more triggers biochemical testing.
Why are the waist cut-offs lower than European ones?
South Asians develop metabolic risk at lower waist circumference and lower BMI. RAPID uses 80 cm in women and 90 cm in men rather than the European thresholds, and PROMPT recommends metformin irrespective of baseline BMI for the same reason.
Which ADA recommendations do not apply in Pakistan?
Eighteen of 243 were excluded — 10 on inpatient care and 4 on paediatrics as outside scope, 2 that depend on private insurance, and 2 for drug unavailability. The one named explicitly is the recommendation to prescribe glucagon for patients at risk of hypoglycaemia, because glucagon is not available in Pakistan.
How does the lack of glucagon change management?
There is no rescue kit to give the family of a patient on insulin or a sulphonylurea. That should make you weigh hypoglycaemia risk more heavily when choosing an agent, be more cautious about chasing a tight HbA1c in frail or comorbid patients, and spend more time teaching the family oral treatment of a hypo.
What are the glycaemic targets?
PROMPT sets HbA1c 6.5 to 7.0% without complications, relaxed to 7.0 to 7.5% in patients with cardiac failure, chronic kidney disease, chronic liver disease or autonomic neuropathy — with correspondingly relaxed fasting and random glucose targets.
How reliable are the Pakistani diabetes guidelines?
The adolopment authors are candid: they state there are not enough original articles published based on the Pakistani population, and that the process relied on regional literature, grey literature and expert consensus at a suboptimal level of evidence. Treat the screening age and availability exclusions as solid; treat fine-grained treatment sequencing as expert opinion adapted from ADA.
Clinically reviewed by Dr Soban Bin Salman Meer, MBBS
MBBS — Postgraduate Trainee in the Department of Urology at the Pakistan Institute of Medical Sciences (PIMS), Islamabad. Graduated from Federal Medical & Dental College, Islamabad.
Sources
PROMPT — Pakistan's Recommendations for Optimal Management of diabetes from Primary to Tertiary care level. Baqai Institute of Diabetology and Endocrinology with the Diabetic Association of Pakistan. Pakistan Journal of Medical Sciences, 2017; a revision of the 1999 national guidelines, intended for two-yearly update. Source of the diagnostic criteria, RAPID score, glycaemic targets and treatment ladder quoted here.
Martins RS, et al. Adolopment of adult diabetes mellitus management guidelines for a Pakistani context: methodology and challenges. Frontiers in Endocrinology, 5 January 2023 — Aga Khan University. GRADE-ADOLOPMENT of the ADA Standards of Medical Care in Diabetes 2021. Source of the 243/219/5/1/18 figures, the screening age adaptation, the exclusion categories, the glucagon unavailability, and the authors' own account of the process limitations.
SCOPE NOTE: this pathway covers screening, diagnosis, targets and initial agent choice. It does not cover complications screening, insulin titration, inpatient or paediatric diabetes — the last two were themselves excluded from the Pakistani adolopment's scope.
Background reading — the full case for screening at 30, the RAPID cut-offs, and what the missing glucagon should change about your prescribing: diabetes in Pakistan.